BIOFRONTERA AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.35 EUR | 0.00% |
|
+4.79% | -12.72% |
| 04-30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-11 | Biofrontera Files Prospectus for Potential Secondary Stock Offerings | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOFRONTERA AG | Other Pharmaceuticals | 0.00% | +4.79% | -12.72% | -69.57% | -94.83% | 23.89M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- B8F Stock
- Charts Biofrontera AG
- Comparison Chart
